These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33108107)

  • 1. RAAS Inhibitors and Risk of Covid-19. Reply.
    Reynolds HR; Adhikari S; Iturrate E
    N Engl J Med; 2020 Nov; 383(20):1993-1994. PubMed ID: 33108107
    [No Abstract]   [Full Text] [Related]  

  • 2. RAAS Inhibitors and Risk of Covid-19. Reply.
    Mancia G; Rea F; Corrao G
    N Engl J Med; 2020 Nov; 383(20):1993. PubMed ID: 33108106
    [No Abstract]   [Full Text] [Related]  

  • 3. RAAS Inhibitors and Risk of Covid-19.
    Strauss MH; Hall AS; Lavie CJ
    N Engl J Med; 2020 Nov; 383(20):1992-1993. PubMed ID: 33108105
    [No Abstract]   [Full Text] [Related]  

  • 4. RAAS Inhibitors and Risk of Covid-19.
    Islam N; Khunti K; Chowell G
    N Engl J Med; 2020 Nov; 383(20):1992. PubMed ID: 33108104
    [No Abstract]   [Full Text] [Related]  

  • 5. RAAS Inhibitors and Risk of Covid-19.
    Sriram K; Loomba R; Insel PA
    N Engl J Med; 2020 Nov; 383(20):1991-1992. PubMed ID: 33108103
    [No Abstract]   [Full Text] [Related]  

  • 6. RAAS Inhibitors and Risk of Covid-19.
    Angeli F; Verdecchia P; Reboldi G
    N Engl J Med; 2020 Nov; 383(20):1990-1991. PubMed ID: 33108102
    [No Abstract]   [Full Text] [Related]  

  • 7. RAAS blockers in hypertension posing a higher risk toward the COVID-19.
    Singh Y; Gupta G; Satija S; Negi P; Chellappan DK; Dua K
    Dermatol Ther; 2020 Jul; 33(4):e13501. PubMed ID: 32359088
    [No Abstract]   [Full Text] [Related]  

  • 8. RAAS inhibitors do not increase the risk of COVID-19.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2020 Jul; 17(7):383. PubMed ID: 32444693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension and RAAS inhibition in times of COVID-19 - current recommendations of the European Society of Hypertension.].
    Limbourg FP
    MMW Fortschr Med; 2020 May; 162(9):67-69. PubMed ID: 32405833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.
    Zheng YY; Ma YT; Zhang JY; Xie X
    Nat Rev Cardiol; 2020 May; 17(5):313-314. PubMed ID: 32231330
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.
    Tedeschi S; Giannella M; Bartoletti M; Trapani F; Tadolini M; Borghi C; Viale P
    Clin Infect Dis; 2020 Jul; 71(15):899-901. PubMed ID: 32339215
    [No Abstract]   [Full Text] [Related]  

  • 12. Inquiring Into Benefits of Independent Activation of Nonclassical Renin-angiotensin System in the Clinical Prognosis and Reduction of COVID-19 Mortality.
    Álvarez-Aragón LM; Cuesta-Muñoz AL; Álvarez-López I
    Clin Infect Dis; 2020 Jul; 71(15):894-895. PubMed ID: 32266375
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
    J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension, RAAS blockade and risk in COVID-19 patients].
    Spaak J; Kahan T
    Lakartidningen; 2020 Jun; 117():. PubMed ID: 32594472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
    Baral R; White M; Vassiliou VS
    Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
    Jarcho JA; Ingelfinger JR; Hamel MB; D'Agostino RB; Harrington DP
    N Engl J Med; 2020 Jun; 382(25):2462-2464. PubMed ID: 32356625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.